A Case of Chronic Myeloid Leukemia with Micro BCR::ABL1 Rearrangement: Precaution in Reverse Transcription PCR to Prevent False Negativity
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
We report a patient negative for BCR::ABL1 in qualitative reverse transcription (RT)-PCR but subsequently reported to be positive for t(9;22)(q34;q11.2) in conventional karyotyping. The patient was finally diagnosed with micro-type chronic myeloid leukemia after re-examining RT-PCR and performing targeted RNA sequencing. Through this case, we highlight the risk of false negativity when interpreting RT-PCR to detect micro-type fusion. Upon re-examining RT-PCR results, the patient’s internal control band was thicker than others. After extending the electrophoresis run time, a 911-bp internal control band and a target band around the level of 1.0 kb were separated. We confirmed a fusion breakpoint (BCR exon 19 and ABL1 exon 2) by targeted RNA sequencing, and it corresponds to 1,012 bp-sized e19a2 (c3a2) type among four micro-type fusion transcripts that RT-PCR HemaVision® kit M6B can detect.
Abstract
We report a patient negative for BCR::ABL1 in qualitative reverse transcription (RT)-PCR but subsequently reported to be positive for t(9;22)(q34;q11.2) in conventional karyotyping. The patient was finally diagnosed with micro-type chronic myeloid leukemia after re-examining RT-PCR and performing targeted RNA sequencing. Through this case, we highlight the risk of false negativity when interpreting RT-PCR to detect micro-type fusion. Upon re-examining RT-PCR results, the patient’s internal control band was thicker than others. After extending the electrophoresis run time, a 911-bp internal control band and a target band around the level of 1.0 kb were separated. We confirmed a fusion breakpoint (BCR exon 19 and ABL1 exon 2) by targeted RNA sequencing, and it corresponds to 1,012 bp-sized e19a2 (c3a2) type among four micro-type fusion transcripts that RT-PCR HemaVision® kit M6B can detect.
참고문헌 (14)
- Melo JV, "The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype", Blood, 88, pp.2375~2384 (1996)
- Ben-Neriah Y, "The chronic myelogenous leukemia-specific P210 protein is the product of the bcr", abl hybrid gene, 1986, pp.233, 212~214
- Ohsaka A, "Philadelphia chromosome-positive chronic myeloid leukemia expressing p190(BCR-ABL)", Intern Med, 41, pp.1183~1187 (2002)
- Komorowski L, "Philadelphia chromosome-positive leukemia in the lymphoid lineage-similarities and differences with the myeloid lineage and specific vulnerabilities", Int J Mol Sci, 21, pp.5776~ (2020)
- Ito T, "Insertion of a genomic fragment of chromosome 19 between BCR intron 19 and ABL intron 1a in a chronic myeloid leukaemia patient with micro-BCR-ABL(e19a2)transcript", Br J Haematol, 126, pp.752~753 (2004)
- Mondal BC, "e19a2 BCR-ABL fusion transcript in typical chronic myeloid leukaemia : a report of two cases", J Clin Pathol, 59, pp.1102~1103 (2006)
- Haskovec C, "P230 BCR", ABL protein may be associated with an acute leukaemia phenotype, 1998, pp.103, 1104~1108
- Kim HY, "The first report of chronic myelogenous leukemia with e19a2 micro-BCR", ABL1 presenting with massive myelofibrosis, 2017, pp.65, 68~70
- 이재현, "Concurrence of e1a2 and e19a2 BCR-ABL1 Fusion Transcripts in a Typical Case of Chronic Myeloid Leukemia", Annals of Laboratory Medicine, 37(1), pp.74~76 (2017), 대한진단검사의학회
- 김지혜, "Micro BCR", ABL 재배열을 가진 비전형적 만성골수성백혈병 1예, 2008, pp.43(3), 184~189[DOI]
- Goh HG, "Comprehensive analysis of BCR-ABL transcript types in Korean CML patients using a newly developed multiplex RT-PCR", Transl Res, 148, pp.249~256 (2006)
- Molica M, "Prognostic significance of transcript-type BCR-ABL1 in chronic myeloid leukemia", Mediterr J Hematol Infect Dis, 12, pp.e2020062~ (2020)
- Engvall M, "Detection of leukemia gene fusions by targeted RNA-sequencing in routine diagnostics", BMC Med Genomics, 13, pp.106~ (2020)
- Langabeer SE, "Standardized molecular monitoring for variant BCR-ABL1 transcripts in chronic myeloid leukemia", Arch Pathol Lab Med, 139, pp.969~ (2015)